COVID-19 patients exhibited a similar elevated IL-32 compared to unexposed controls (+0.29 ± 0.11 log<sub>10</sub> pg/ml, p=0.016; 2.43 ± 0.08 hospital admission vs. pre-pandemic). The gene discussed is IL32; the disease is COVID-19.